Jamison Private Wealth Management, Inc. Caribou Biosciences, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $657 Billion
- Q3 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 188 shares of CRBU stock, worth $372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188
Previous 188
-0.0%
Holding current value
$372
Previous $309,000
19.42%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
52.6MCall Options Held
148KPut Options Held
70.7K-
Black Rock Inc. New York, NY6.95MShares$13.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$9.14 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$9.05 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.31MShares$8.53 Million0.49% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.36MShares$4.67 Million0.38% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $120M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...